SCHEMBL4906349

SCHEMBL4906349

CCN(c1nc(-c2ccc(C(F)(F)F)cc2)sc1C)S(=O)(=O)c1ccc(Cl)c(C(=O)OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
TSHR P16473 2/20 0.50
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
MAPT P10636 4/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
KDM4E B2RXH2 2/20 0.41
HSP90AA1 P07900 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
GAA P10253 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPC1 O15118 1/20 0.38
TRPM8 Q7Z2W7 3/20 0.38
TP53 P04637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
MCL1 Q07820 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905533 0.92 KDM4E (0.42) ALDH1A1TSHRMAPTKMT2AMEN1
SCHEMBL4900703 0.91 KDM4E (0.41) ALDH1A1TSHRMAPTKMT2AMEN1
SCHEMBL4894397 0.91 MEN1 (0.49) HCRTR1HCRTR2MAPTKMT2AMEN1
SCHEMBL4904036 0.91 ALDH1A1 (0.54) ALDH1A1TSHRMAPTKMT2AMEN1
SCHEMBL4903085 0.89 GAA (0.40) ALDH1A1TSHRMAPTKMT2AMEN1
SCHEMBL4906041 0.88 ALDH1A1 (0.52) ALDH1A1TSHRMAPTKDM4EGAA
SCHEMBL4900544 0.87 KDM4E (0.41) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL4906254 0.84 NR1I2 (0.40) ALDH1A1TSHRHCRTR2MAPTKMT2A
SCHEMBL4905594 0.84 TRPM8 (0.42) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL4906767 0.84 ALDH1A1 (0.44) ALDH1A1TSHRMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885HCRTR1 4146/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885HCRTR1 4148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.